drs. J.R. (Janneke) Zinkstok

drs. J.R. (Janneke) Zinkstok

Assistant Professor - medical
drs. J.R. (Janneke) Zinkstok
  • Psychiatry



Dr. Janneke Zinkstok trained as a Medical Doctor and subsequently as a Psychiatrist in Amsterdam, the Netherlands, and completed a PhD in Psychiatric Genetics (University of Amsterdam). She worked as a Clinical Research Fellow in the Institute of Psychiatry, King’s College London, where she studied brain structure in Autism Spectrum Disorders, and specialized in developmental disorders in adults at the Maudsley Hospital. She is now a Psychiatrist at the Department of Psychiatry at the UMC Utrecht, The Netherlands. Her clinical and research interests include the neurobiology of brain development and psychiatric disorders especially neurodevelopmental disorders (ADHD and autism) and psychosis, and 22q11.2 deletion syndrome.

Key publications

  1. Zinkstok, J, Boot, E, Bassett, AS, Hiroi, N, Butcher, NJ, Vingerhoets, C, Vorstman, JAS, & van Amelsvoort, TAMJ. The 22q11.2 deletion syndrome from a neurobiological perspective. 2019, in press Lancet Psychiatry.

  2. Boer J, Boot E,  van Gils L, van Amelsvoort T, Zinkstok J.  Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review. in press American Journal of Medical Genetics Part A.
  3. Boer J, Vingerhoets C, Hirdes M, McAlonan GM, Amelsvoort T, Zinkstok J. Efficacy and tolerability of riluzole in psychiatric disorders: a systematic review and preliminary meta-analysis. Psychiatry Research 2019 Aug; 278:294-302.
  4. Ajram L, Horder J, Mendez M, Galanopoulos A, Brennan L, Wichers R, Robertson D, Murphy C, Zinkstok J, Ivin G, Heasman M, Meek D, Tricklebank M, Barker G, Lythgoe D, Edden R, Williams SC, Murphy D, McAlonan G. Shifting prefrontal Excitation-Inhibition balance and functional connectivity in Autism Spectrum Disorder. Translational Psychiatry 2017 May 23;7(5):e1137.
  5. Wilson CE, Murphy CM, McAlonan G, Robertson DM, Spain D, Hayward H, Woodhouse E, Deeley PQ, Gillan N, Ohlsen JC, Zinkstok J, Stoencheva V, Faulkner J, Yildiran H, Bell V, Hammond N, Craig MC, Murphy DG. Does sex influence the diagnostic evaluation of autism spectrum disorder in adults? Autism 2016 Oct;20(7):808-19.
  6. Russell AJ, Murphy CM, Wilson E, Gillan N, Brown C, Robertson DM, Craig MC, Deeley Q, Zinkstok J, Johnston K, McAlonan GM, Spain D, Murphy DG. The mental health of individuals referred for assessment of autism spectrum disorder in adulthood: A clinic report. Autism 2015 Jul;20(5):623-7.
  7. Deoni S & Zinkstok J [joint first authors], Daly E, Johnston P, Ecker C, AIMS Consortium, Murphy D.  Is brain myelination altered in autism? An in vivo MRI study. Psychological Medicine 2015, 45(4):795-805.
  8. Wilson C, Gillan N, Spain D, Robertson D, Roberts G, Murphy CM, Maltezos S, Zinkstok J, Johnston K, Dardani C, Ohlsen C, Deeley P, Craig M, Mendez M, Happé F, Murphy D.  Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an Adult Autism Spectrum Disorder Diagnostic Clinic. J Autism Dev Disord 2013, 43(11):2515-25.
  9. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, Fantini C, Breviere GM, Di Rosa G, Pustorino G, Vogels A, Swillen A, Legallic S, Bou J, Opolczynski G, Drouin-Garraud V, Lemarchand M, Philip N, Gerard-Desplanches A, Carlier M, Philippe A, Nolen MC, Heron D, Sarda P, Lacombe D, Coizet C, Alembik Y, Layet V, Afenjar A, Hannequin D, Demily C, Petit M, Thibaut F, Frebourg T, Campion D. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Human Molecular Genetics 2007, 1;16(1):83-91.
  10. Zinkstok J, van Amelsvoort T. Neuropsychological profile and neuroimaging in patients with 22q11.2 Deletion Syndrome: a review. Child Neuropsychology 2005, 1: 21-37.

Research Output (44)

Untargeted metabolic analysis in dried blood spots reveals metabolic signature in 22q11.2 deletion syndrome

Korteling Dorinde, Boks Marco P, Fiksinski Ania M, van Hoek Ilja N, Vorstman Jacob A S, Verhoeven-Duif Nanda M, Jans Judith J M, Zinkstok Janneke R 9 Mar 2022, In: Translational Psychiatry. 12 , p. 1-7

Transcriptomic profiling of whole blood in 22q11.2 reciprocal copy number variants reveals that cell proportion highly impacts gene expression

Lin Amy, Forsyth Jennifer K, Hoftman Gil D, Kushan-Wells Leila, Jalbrzikowski Maria, Dokuru Deepika, Coppola Giovanni, Fiksinski Ania, Zinkstok Janneke, Vorstman Jacob, Nachun Daniel, Bearden Carrie E Dec 2021, In: Brain, behavior, & immunity - health. 18 , p. 1-13

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome:protocol for a series of N-of-1 trials

Müller A. R., Zinkstok J. R., Rommelse N. N.J., van de Ven P. M., Roes K. C.B., Wijburg F. A., de Rooij-Askes E., Linders C., Boot E., van Eeghen A. M. Dec 2021, In: Orphanet Journal of Rare Diseases. 16 , p. 1-9


Zinkstok Janneke, Korteling Dorinde, Fiksinski Ania, Jans Judith, Verhoeven Nanda, Boks Marco Oct 2021, In: European Neuropsychopharmacology. 51 , p. E130-E130

Parkinsonism in individuals with genetic neurodevelopmental disorders: A systematic review

Scheibler E., Kuijf M., Koning T., Zinkstok J., Muller A., Amelsvoort T., Eeghen A., Boot E. Sep 2021, In: Movement Disorders. 36 , p. S320-S321

Psychiatric phenotypes associated with hyperprolinemia:A systematic review

Namavar Yasmin, Duineveld Denise Joanne, Both Geertje Ingena Angelique, Fiksinski Ania Maria, Vorstman Jacob Abraham Schrey, Verhoeven-Duif Nanda Margriet, Zinkstok Janneke Rozemarijn 24 Jul 2021, In: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 186 , p. 289-317 29 p.

De jeugd heeft de toekomst?:Over armoede, hersenontwikkeling en psychiatrie

Zinkstok Janneke R. May 2021, In: Tijdschrift voor Psychiatrie. 63 , p. 317-319 3 p.

Neurodevelopmental Trajectories and Psychiatric Morbidity:Lessons Learned From the 22q11.2 Deletion Syndrome

Fiksinski Ania M, Schneider Maude, Zinkstok Janneke, Baribeau Danielle, Chawner Samuel J R A, Vorstman Jacob A S Mar 2021, In: Current Psychiatry Reports. 23

Polygenic Risk Scores for Genetic Counseling in Psychiatry:Lessons Learned from other Fields of Medicine

Eeltink E, van der Horst M Z, Zinkstok J R, Aalfs C M, Luykx J J Feb 2021, In: Neuroscience and Biobehavioral Reviews. 121 , p. 119-127 9 p.

Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain:the Metformin-Lifestyle in antipsychotic users (MELIA) trial

de Boer Nini, Guloksuz Sinan, van Baal Caroline, Willebrands Leonie, Deenik Jeroen, Vinkers Christiaan H., Rossum Inge Winter van, Zinkstok Janneke, Wilting Ingeborg, Zantvoord Jasper B., Backx Frank, Swildens Wilma E., Schouw Marieke, Bogers Jan, Hulshof Folkwin, de Knijff Rudolf, Duindam Peter, Veereschild Mike, Bak Maarten, Frederix Geert, de Haan Lieuwe, van Os Jim, Cahn Wiepke, Luykx Jurjen J. 5 Jan 2021, In: BMC Psychiatry. 21

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet